Alzamend Neuro is trading 7.12% down at $1.56 in after-hours trading after closing at $1.68 on September 8, 2026, as investors may be positioning cautiously ahead of the expected September 9 earnings release.
- No confirmed company-specific after-hours announcement was identified.
- Consensus calls for a $0.56 loss and zero revenue.
- Broader risk-off sentiment weighed on markets: the S&P 500 fell 0.55% and the Dow declined 1.10%.